I-Mab Operating Expenses 2011-2026 | IMAB

Annual Operating Expenses I-Mab

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	1.49 B	-	-	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
1.49 B	1.49 B	1.49 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	216 M	$ 16.84	-2.69 %	$ 787 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 7.46	-4.79 %	$ 204 M	Israel
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Fennec Pharmaceuticals FENC	50.9 M	$ 9.59	3.79 %	$ 274 M	USA
AbCellera Biologics ABCL	292 M	$ 4.06	-7.77 %	$ 1.21 B	Canada
Compugen Ltd. CGEN	40.4 M	$ 2.84	-6.44 %	$ 265 M	Israel
Autolus Therapeutics plc AUTL	145 M	$ 1.57	-1.09 %	$ 418 M	Britain
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioNTech SE BNTX	512 M	$ 88.82	-3.45 %	$ 21.5 B	Germany
Coherus BioSciences CHRS	231 M	$ 1.57	-3.44 %	$ 184 M	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 0.72	-1.76 %	$ 32.9 M	Israel
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Esperion Therapeutics ESPR	343 M	$ 3.13	0.16 %	$ 651 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 29.76	-0.67 %	$ 801 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Exelixis EXEL	598 M	$ 50.29	-1.59 %	$ 13.7 B	USA
Arcutis Biotherapeutics ARQT	305 M	$ 21.66	0.42 %	$ 2.76 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Fortress Biotech FBIO	125 M	$ 2.44	6.3 %	$ 68.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Forte Biosciences FBRX	70.7 M	$ 22.55	-5.88 %	$ 292 M	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA